Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.3M Buy
295,898
+198,194
+203% +$42.5M 0.15% 111
2026
Q1
$21.6M Sell
97,704
-64,812
-40% -$15.9M 0.07% 430
2025
Q4
$41.2M Sell
162,516
-1,341
-0.8% -$337K 0.15% 109
2025
Q3
$40.5M Buy
163,857
+34,003
+26% +$8.14M 0.18% 64
2025
Q2
$31.2M Buy
129,854
+34,469
+36% +$8.03M 0.19% 62
2025
Q1
$21.6M Sell
95,385
-7,778
-8% -$1.71M 0.18% 82
2024
Q4
$21.2M Buy
103,163
+9,615
+10% +$2.11M 0.2% 68
2024
Q3
$22.7M Buy
93,548
+8,106
+9% +$1.9M 0.23% 40
2024
Q2
$18.8M Buy
85,442
+72,002
+536% +$15.6M 0.24% 38
2024
Q1
$3.02M Buy
13,440
+6,052
+82% +$1.37M 0.05% 520
2023
Q4
$1.62M Sell
7,388
-757
-9% -$160K 0.03% 675
2023
Q3
$1.79M Buy
8,145
+119
+1% +$26.9K 0.04% 587
2023
Q2
$1.81M Sell
8,026
-1,522
-16% -$305K 0.04% 577
2023
Q1
$1.83M Buy
9,548
+2,038
+27% +$394K 0.04% 546
2022
Q4
$1.39M Sell
7,510
-1,134
-13% -$199K 0.04% 567
2022
Q3
$1.44M Buy
8,644
+3,558
+70% +$724K 0.04% 523
2022
Q2
$1.05M Buy
5,086
+360
+8% +$81.2K 0.03% 552
2022
Q1
$1.14M Buy
4,726
+132
+3% +$30.6K 0.04% 524
2021
Q4
$1.12M Buy
4,594
+821
+22% +$188K 0.04% 511
2021
Q3
$771K Sell
3,773
-54
-1% -$11.6K 0.03% 541
2021
Q2
$790K Sell
3,827
-1,629
-30% -$328K 0.03% 554
2021
Q1
$1.04M Sell
5,456
-18,077
-77% -$3.35M 0.05% 455
2020
Q4
$4.46M Sell
23,533
-4,123
-15% -$769K 0.15% 201
2020
Q3
$4.87M Sell
27,656
-18,101
-40% -$2.89M 0.16% 188
2020
Q2
$7.02M Buy
45,757
+40,578
+784% +$6.18M 0.21% 125
2020
Q1
$725K Sell
5,179
-11,610
-69% -$1.74M 0.02% 637
2019
Q4
$2.56M Sell
16,789
-18,450
-52% -$2.7M 0.05% 403
2019
Q3
$5.09M Sell
35,239
-31,418
-47% -$4.69M 0.09% 280
2019
Q2
$9.92M Sell
66,657
-1,822
-3% -$243K 0.16% 180
2019
Q1
$8.77M Buy
68,479
+758
+1% +$89.2K 0.13% 239
2018
Q4
$7.24M Sell
67,721
-39,166
-37% -$4.37M 0.11% 258
2018
Q3
$12.2M Buy
106,887
+81,330
+318% +$9.2M 0.17% 185
2018
Q2
$2.68M Buy
25,557
+9,227
+57% +$928K 0.04% 433
2018
Q1
$1.52M Buy
16,330
+195
+1% +$17.7K 0.02% 546
2017
Q4
$1.41M Sell
16,135
-39,220
-71% -$3.5M 0.02% 541
2017
Q3
$4.89M Sell
55,355
-116,873
-68% -$9.91M 0.07% 366
2017
Q2
$14M Buy
172,228
+119,317
+226% +$9.07M 0.2% 165
2017
Q1
$3.67M Sell
52,911
-3,543
-6% -$245K 0.05% 451
2016
Q4
$3.8M Sell
56,454
-5,071
-8% -$344K 0.05% 421
2016
Q3
$4.5M Buy
+61,525
New +$4.35M 0.06% 373
2015
Q4
Sell
-61,303
Closed -$3.98M 1002
2015
Q3
$3.98M Sell
61,303
-434,498
-88% -$28.7M 0.04% 451
2015
Q2
$31.9M Buy
+495,801
New +$33.4M 0.27% 127
2015
Q1
Sell
-5,127
Closed -$332K 1019
2014
Q4
$332K Buy
+5,127
New +$317K ﹤0.01% 804
2014
Q3
Sell
-17,236
Closed -$922K 1065
2014
Q2
$922K Buy
17,236
+1,187
+7% +$61.1K 0.01% 663
2014
Q1
$766K Buy
+16,049
New +$752K 0.01% 709
2013
Q3
Sell
-9,904
Closed -$425K 950
2013
Q2
$425K Buy
+9,904
New +$426K 0.02% 689

Other funds holding STE

Joel Greenblatt's STE Position: Q2 2026 in Review

Joel Greenblatt increased its Steris (STE) stake by 203% in Q2 2026, buying an estimated $42.5M and bringing the position to 295,898 shares worth $62.3M. The position accounts for 0.15% of the portfolio, ranked #111.

Joel Greenblatt first reported a position in STE in Q2 2013 and has held it in 46 quarters since. 828 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Joel Greenblatt held 295,898 shares of Steris worth $62.3M as of Q2 2026.
  • Joel Greenblatt bought 198,194 Steris shares in Q2 2026, an estimated $42.5M.
  • Steris made up 0.15% of Joel Greenblatt's portfolio in Q2 2026, its #111 holding.
  • Joel Greenblatt first reported a position in Steris in Q2 2013 and has held it in 46 quarters since.
  • 828 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.